期刊文献+

补肾益肝活血胶囊对去卵巢大鼠骨质疏松症的影响 被引量:4

Effect of Bushenyiganhuoxue capsule on osteoposis of off-ovary rats
原文传递
导出
摘要 目的 观察补肾益肝活血胶囊对去卵巢大鼠骨质疏松症的影响。方法 6月龄大鼠随机分为假手术组(N)、模型组(O)、模型+尼尔雌醇处理组(O +E)、模型+补肾益肝活血胶囊处理组(O +M )。治疗90d后,测定尿脱氧吡啶啉/肌酐比率(urinarydeoxypyridinotinecrosstink/crertinine,udpd/Cr) ,血Ca、palp、尿Ca/Cr等生化指标,观测股骨近端骨密度、组织形态学变化情况。结果 模型+补肾益肝活血胶囊处理组(O+M)骨密度增加,尿脱氧吡啶啉/肌酐比率显著下降,血钙、血磷显著增高,碱性磷酸酶下降。结论 补肾益肝活血胶囊不仅能抑制骨吸收,还能促进骨形成,具有较好的防治骨质疏松作用。 Objective To observe the effect of Bushenyiganhuoxue capsule on osteoporosis of off-ovary rats.Methods Six-month rats were divided randomly into four groups:pseudo-operation group(N),model group(O),model-and-nylestriol group(O+E) and model-and-Bushenyiganhuoxue capsule group(O+M).90 days later,urinary dexoxypyridinotine scorrtink/crertin-ine(udpd/Cr)ratio,plasma Ca palp and urinary Ca/Cr were detected.Meanwhile we observed osteodensity of thighbone and tectolgy changing.Results In group (O+M),osteodensity increased and udpd/Cr de-creased markedly,with increased plasma Ca plasma P,and decreased alkaline phosphatase.Conclusion Bushenyiganhuoxue capsule can not only restrain osteo-absorption,but also accelerate osteogenesis,it a preferable action of preventing osteoporosis.
出处 《中国基层医药》 CAS 2005年第4期416-417,共2页 Chinese Journal of Primary Medicine and Pharmacy
基金 珠海市科技项目 (PC2 0 0 410 2 3 )
关键词 补肾益肝活血胶囊 去卵巢大鼠 骨质疏松 尿脱氧吡啶啉 Bushenyiganhuoxue capsule Osteoporosis Ovariectomy,rats Models,animal
  • 相关文献

参考文献5

二级参考文献26

  • 1李青南,吴铁,谢华,黄莲芳,张志平.淫羊藿提取液对去睾丸大鼠骨代谢的影响[J].中草药,1993,24(12):637-638. 被引量:87
  • 2罗为民,符诗聪,杜宁,曲克服,李国衡.健脾补肾法防治绝经后骨质疏松症的计量学研究[J].中国中医骨伤科,1995,3(2):1-4. 被引量:44
  • 3刘忠厚,段云波,马海波,肖艳霞,张卫,吴元沧,刘京萍.骨质疏松症的诊断和筛选[J].中国老年学杂志,1995,15(1):53-57. 被引量:35
  • 4谢林,姚共和,郭振球.健脾养胃法治疗骨质疏松症初探[J].湖南中医学院学报,1996,16(4):7-9. 被引量:31
  • 5World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis.WHO Technical Report Series. Geneva: WHO, 1994. 843.
  • 6Ouillon R, Burkhardt P, Christiansen C, et al. Concensus development conference: prophylaxis and treatment of osteoporosis. Osteoporosis Int, 1991, 1:114-117.
  • 7Zhan Z, Yamamoto I, Morita R. Urinary pyridinoline and deoxypyridinoline as bone metabolic markers in predicting therapeutie effects of estrogen and alfacaleidol in women with osteoporesis. J Bone Miner Metab, 1999, 17(2):113-118.
  • 8Bauer DC, Black DM, Gamero P, et al. Reduction in bone tumover predicts hip, non-spine, and vertebral fracture in alendronate treated women: the fracture intervention trial.J Bone Miner Res, 2002, 17(suppl 1):S187.
  • 9Pardini DP, Sabino AT, Meneses AM, et al. Effect of hormone replacement therapy on the bone mass and urinary excretion of pyddinium cross-links. Sao Paulo Med J,2000, 118(1):3-6.
  • 10Meng XW, Liang GX, Birchman R, et al.Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res,421-429.

共引文献147

同被引文献37

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部